Literature DB >> 21030684

Determining stability of stored samples retrospectively: the validation of glycated albumin.

David M Nathan1, Michael W Steffes, Wanjie Sun, Gregory P Rynders, John M Lachin.   

Abstract

BACKGROUND: Determining the stability of stored samples for assays that were not available at the time of original collection is problematic. To assess sample stability for a relatively new assay of glycated albumin (GA), we first measured GA in fresh samples and in samples stored for 19-23 years. We then compared the regression of the contemporaneous glycohemoglobin (Hb A(1c)) values against the GA results from fresh vs stored samples, reasoning that similar slopes and intercepts would provide strong, albeit indirect, support for the stability of the stored samples for GA measurements.
METHODS: We assayed 90 samples frozen for 19-23 years and 90 fresh samples from participants in the Diabetes Control and Complications trial cohort for GA. Hb A(1c) was measured contemporaneously in fresh samples at each time period. A single normal-errors linear model regressed the Hb A(1c) values on the GA, with an additional effect for collection period (fresh vs stored for GA) and the interaction of period and GA.
RESULTS: Analysis of the regressions lines between GA and Hb A(1c) revealed intercepts (3.69 and 2.97 for the fresh and stored samples, respectively) and slopes (0.198 vs 0.187) that were not significantly different (P = 0.182 and P = 0.639, respectively).
CONCLUSIONS: This simple approach can be used to assess the stability of stored samples in new assays. Samples stored for as long as 23 years are suitable for the GA assay.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21030684     DOI: 10.1373/clinchem.2010.150250

Source DB:  PubMed          Journal:  Clin Chem        ISSN: 0009-9147            Impact factor:   8.327


  23 in total

1.  Basic performance of an enzymatic method for glycated albumin and reference range determination.

Authors:  Takuji Kohzuma; Tamotsu Yamamoto; Yumiko Uematsu; Zak K Shihabi; Barry I Freedman
Journal:  J Diabetes Sci Technol       Date:  2011-11-01

2.  Racial Differences in and Prognostic Value of Biomarkers of Hyperglycemia.

Authors:  Christina M Parrinello; A Richey Sharrett; Nisa M Maruthur; Richard M Bergenstal; Morgan E Grams; Josef Coresh; Elizabeth Selvin
Journal:  Diabetes Care       Date:  2015-12-17       Impact factor: 19.112

Review 3.  Recent topics in chemical and clinical research on glycated albumin.

Authors:  Yuki Ueda; Hideyuki Matsumoto
Journal:  J Diabetes Sci Technol       Date:  2015-01-21

4.  Glycated albumin is stable in plasma when exposed to common laboratory conditions and comparable when drawn from venous or capillary sites.

Authors:  Andrew N Reynolds; Michelle Harper; Bernard J Venn; Jim Mann
Journal:  J Clin Lab Anal       Date:  2017-04-25       Impact factor: 2.352

5.  Utility of glycated albumin for the diagnosis of diabetes mellitus in a Japanese population study: results from the Kyushu and Okinawa Population Study (KOPS).

Authors:  N Furusyo; T Koga; M Ai; S Otokozawa; T Kohzuma; H Ikezaki; E J Schaefer; J Hayashi
Journal:  Diabetologia       Date:  2011-09-27       Impact factor: 10.122

6.  The establishment of biological reference intervals of nontraditional glycemic markers in a Chinese population.

Authors:  Qiang Zhou; De-Bao Shi; Li-Ying Lv
Journal:  J Clin Lab Anal       Date:  2016-11-17       Impact factor: 2.352

7.  Establishment of Community-Based Reference Intervals for Fructosamine, Glycated Albumin, and 1,5-Anhydroglucitol.

Authors:  Elizabeth Selvin; Bethany Warren; Xintong He; David B Sacks; Amy K Saenger
Journal:  Clin Chem       Date:  2018-02-07       Impact factor: 8.327

Review 8.  Glucose targets for preventing diabetic kidney disease and its progression.

Authors:  Marinella Ruospo; Valeria M Saglimbene; Suetonia C Palmer; Salvatore De Cosmo; Antonio Pacilli; Olga Lamacchia; Mauro Cignarelli; Paola Fioretto; Mariacristina Vecchio; Jonathan C Craig; Giovanni Fm Strippoli
Journal:  Cochrane Database Syst Rev       Date:  2017-06-08

9.  Associations of alternative markers of glycemia with hemoglobin A(1c) and fasting glucose.

Authors:  Stephen P Juraschek; Michael W Steffes; Elizabeth Selvin
Journal:  Clin Chem       Date:  2012-09-27       Impact factor: 8.327

10.  Traditional and nontraditional glycemic markers and risk of peripheral artery disease: The Atherosclerosis Risk in Communities (ARIC) study.

Authors:  Ning Ding; Lucia Kwak; Shoshana H Ballew; Bernard Jaar; Ron C Hoogeveen; Christie M Ballantyne; A Richey Sharrett; Aaron R Folsom; Gerardo Heiss; Maya Salameh; Josef Coresh; Alan T Hirsch; Elizabeth Selvin; Kunihiro Matsushita
Journal:  Atherosclerosis       Date:  2018-04-30       Impact factor: 5.162

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.